Kramer Levin Naftalis & Frankel
Corprate Bias Ratings
Kramer Levin Naftalis & Frankel scored a 90 on the Human Rights Campaign’s (HRC) Corporate Equality Index (CEI). By complying with the HRC’s controversial demands, the company increases the risk of dividing employees, alienating customers and harming shareholders. The company covers transgender-related medical costs for its employees and their children and provides specific sexual orientation and gender identity-based benefits. Kramer Levin forces employees to undergo multiple ideological trainings and uses its reputation, corporate funds, and political influence to support controversial sex and gender ideologies, organizations, and legislation. Kramer Levin does not provide its employees with protections against viewpoint discrimination. The company is Mansfield Certified, indicating its support of DEI in its recruitment, hiring, promotions, and leadership composition. Kramer Levin is a pro bono partner of the Center for Reproductive Rights, building case law, advocating before policy makers, and engaging in litigation to challenge bans and restrictions on access to abortion. However, it has not publicly terminated business relationships based on views or beliefs. Kramer Levin likely does not discriminate against religious organizations in its charitable giving. For these reasons, Kramer Levin Naftalis & Frankel receives a Medium Risk rating.
Has denied service to customers, suppliers, or vendors due to their political views or religious beliefs OR corporately boycotts, divests, or sanctions regions, people groups, or industries.
Charitable giving (including employee matching programs) policies or practices discriminate against charitable organizations based on views or religious beliefs.
Kramer Levin likely does not discriminate against religious organizations in its charitable giving, with some pro bono efforts being dedicated to religious organizations (1).
Uses corporate reputation to support ideological causes and/or organizations hostile to freedom of expression.
Uses corporate funds to advance ideological causes, organizations, or policies hostile to freedom of expression.
Kramer Levin’s HRC 2023 CEI rating indicates the company covers transgender related costs for its employees and their children, including paid short-term leave, puberty blockers, cross-sex hormones, chest surgeries, genital surgeries, medical visits and lab monitoring, travel and lodging. Additionally, the company has pledged philanthropic support of at least one organization or event that promotes sex and gender ideology (1)(2). By allowing a political stakeholder group to dictate operations, the company increases health care costs and risks dividing employees, alienating customers and harming shareholders. The firm has been engaged in several pro bono LGBT-related cases (3).
All links were last accessed and all information was updated on:
February 15, 2024
Company reports are intended for educational use only. Full Disclaimer